Patent · US Active

Human serum albumin in formulations

US11241499B2 · kind B2 · utility

0Cited by
0References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 3, 2020
Grant dateFeb 8, 2022
Priority date—
Expiry dateMar 3, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/26
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Drug formulations and methods for removing, reducing, or preventing the formation of fatty acid particles in drug formulations are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.